Back to search results

iHeart DepCare for Depression in Heart Disease Patients

This study is testing a tool called iHeart DepCare to help people with heart disease who also have depression. The iHeart DepCare tool is an electronic program that helps bridge depression screening with treatment. It includes information about depression symptoms and behavioral risk factors. Researchers want to see if using this tool helps more people start or continue treatment for their depression. You may be able to join if you are over 18, have heart disease, and have certain scores on a depression screening. The study aims to enroll 200 participants. The current status of the study is unclear.

Study design
This is an interventional study that plans to enroll 200 participants. Participants will be randomly assigned to either receive usual care or the iHeart DepCare tool with support.
What's involved
Participants will receive the iHeart DepCare tool along with brief motivational, technical, and navigation support based on their preference. Depression treatment initiation or intensification will be measured for up to 6 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 6 months to measure whether they start or intensify depression treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07390331

A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients

Recruiting
NAAges 18+InterventionalHealth services
Columbia University
~200 participants
Updated 2026-03-06 on ClinicalTrials.gov
What's tested:iHeart Depcare tool

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of eligible patients who initiate or intensify depression treatment
Measured over Up to 6 months

Conditions

Depression and CVD

Explore related trials

Coronary heart diseaseDepression

NCT07390331

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Columbia University Irving Medical Center

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Nathalie Moise, MD, MS, FAHA · PRINCIPAL_INVESTIGATOR · Columbia University

Who to contact

Nathalie Moise, MD, MS, FAHA
[email protected]
212-342-2889
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Over 18 years of age
PHQ9 or PHQ8 score \>=8
History of coronary heart disease per EHR search for ICD-9 codes of 410-414 and ICD-10 codes: I20, I21, I22, I23, I24, I25.
Appointment with a primary care provider (PCP) or cardiologist in an integrated care setting in NYP/Columbia (e.g., does not include procedure or lab-only visits)
Has a PCP at NYP/Columbia active on the NYP/Columbia EHR

Exclusion

Not English or Spanish speaking
History of severe mental illness (bipolar disorder, schizophrenia, chronic/recurrent depression, history of suicide attempt or self-inflicted injuries)
Dementia
Had an integrated mental health visit in the last 3 months as indicated in the EHR
Enrollment in the post-implementation period of IRB# AAAR9175

What this trial measures

  • Percentage of eligible patients who initiate or intensify depression treatmentUp to 6 months

    This is designed to measure depression treatment reach, which is defined as the percentage of eligible patients who initiate or intensify depression treatment within 6 months of the index visit, as indicated by ≥1 pharmacy fill data of a new or changed antidepressant and/or a new visit with a mental health provider (e.g., psychologist, psychiatrist, behavioral health provider like social workers) and/or primary care provider with a visit diagnosis of depression and/or an exercise program (e.g., cardiac rehabilitation), which will be assessed through chart extraction and tallied.